Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation
Richard Li(Brigham and Women's Hospital), Karen J. Marcus(Harvard University), Lisa Diller(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Katherine K. Matthay(University of California System), Alexei L. Polishchuk(University of California, San Francisco), Rochelle Bagatell(Children's Hospital of Philadelphia), Christine E. Hill‐Kayser(University of Pennsylvania), Suzanne Shusterman(Dana-Farber Cancer Institute), Stephanie W. Lee(Brigham and Women's Hospital), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Hasan Al‐Sayegh(Sultan Qaboos University), Steven G. DuBois(University of California, San Francisco), Randall A. Hawkins(UCSF Benioff Children's Hospital), Wendy B. London(Dana-Farber Cancer Institute)
International Journal of Radiation Oncology*Biology*Physics
November 8, 2016
Cited by 30
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
|Pediatric Blood & Cancer|2013|459
Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
|Journal of Clinical Oncology|2009|418
Artificial intelligence in radiation oncology
|Nature Reviews Clinical Oncology|2020|399